Jan J. Cornelissen

31.6k total citations · 3 hit papers
319 papers, 13.0k citations indexed

About

Jan J. Cornelissen is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Jan J. Cornelissen has authored 319 papers receiving a total of 13.0k indexed citations (citations by other indexed papers that have themselves been cited), including 234 papers in Hematology, 88 papers in Public Health, Environmental and Occupational Health and 69 papers in Oncology. Recurrent topics in Jan J. Cornelissen's work include Hematopoietic Stem Cell Transplantation (178 papers), Acute Myeloid Leukemia Research (120 papers) and Acute Lymphoblastic Leukemia research (84 papers). Jan J. Cornelissen is often cited by papers focused on Hematopoietic Stem Cell Transplantation (178 papers), Acute Myeloid Leukemia Research (120 papers) and Acute Lymphoblastic Leukemia research (84 papers). Jan J. Cornelissen collaborates with scholars based in Netherlands, France and Germany. Jan J. Cornelissen's co-authors include Bob Löwenberg, Didier Blaise, Bronno van der Holt, Mohamad Mohty, Leo F. Verdonck, Albert D. M. E. Osterhaus, Joost W. J. van Esser, Hubert G.M. Niesters, Aloïs Gratwohl and Jan W. Gratama and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jan J. Cornelissen

307 papers receiving 12.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human fetal lymphoid tissue–inducer cells are interleukin 17–producing precursors to RORC+ CD127+ natural killer–like cells

2008 542 citations Jan J. Cornelissen et al. profile →
Acute myeloid leukaemia

2016 289 citations Jan J. Cornelissen et al. profile →
Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome

2022 159 citations Tim Grob, Adil S. A. Al Hinai et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan J. Cornelissen Netherlands	58	7.1k	3.4k	2.9k	2.6k	2.3k	319	13.0k
Richard T. Maziarz United States	59	7.5k 1.1×	4.0k 1.2×	2.6k 0.9×	1.3k 0.5×	2.3k 1.0×	361	13.1k
Jeff Szer Australia	58	8.4k 1.2×	3.5k 1.0×	4.8k 1.6×	1.8k 0.7×	1.9k 0.8×	385	15.3k
Ted Gooley United States	73	10.3k 1.5×	4.9k 1.4×	4.7k 1.6×	2.6k 1.0×	3.0k 1.3×	322	18.3k
Nöel Milpied France	65	6.1k 0.9×	5.3k 1.5×	2.7k 0.9×	2.2k 0.8×	1.8k 0.8×	423	13.9k
Rodrigo Martino Spain	56	5.1k 0.7×	2.8k 0.8×	1.9k 0.6×	3.4k 1.3×	1.5k 0.6×	313	10.4k
Hildegard Greinix Austria	47	5.6k 0.8×	1.9k 0.6×	2.6k 0.9×	1.4k 0.5×	1.2k 0.5×	244	8.9k
Reuven Or Israel	44	6.6k 0.9×	2.6k 0.8×	3.5k 1.2×	1.4k 0.5×	1.4k 0.6×	303	10.8k
Donna Przepiorka United States	59	12.0k 1.7×	5.5k 1.6×	5.6k 1.9×	1.9k 0.7×	2.6k 1.1×	197	18.2k
Mary E.D. Flowers United States	77	14.2k 2.0×	4.8k 1.4×	5.4k 1.8×	2.9k 1.1×	3.9k 1.7×	339	20.0k
Nicolaus Kröger Germany	70	12.0k 1.7×	5.1k 1.5×	3.4k 1.2×	1.1k 0.4×	2.7k 1.1×	583	17.0k

Countries citing papers authored by Jan J. Cornelissen

Since Specialization

Citations

This map shows the geographic impact of Jan J. Cornelissen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan J. Cornelissen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan J. Cornelissen more than expected).

Fields of papers citing papers by Jan J. Cornelissen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan J. Cornelissen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan J. Cornelissen. The network helps show where Jan J. Cornelissen may publish in the future.

Co-authorship network of co-authors of Jan J. Cornelissen

This figure shows the co-authorship network connecting the top 25 collaborators of Jan J. Cornelissen. A scholar is included among the top collaborators of Jan J. Cornelissen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan J. Cornelissen. Jan J. Cornelissen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wynn, Robert, Fernanda Volt, Philippe Guardiola, et al.. (2025). Impact of shared HLA determinants between patient and losing cord blood unit on relapse after double cord blood transplantation. Blood Advances. 9(17). 4425–4435. 2 indexed citations

Giebel, Sebastian, Myriam Labopin, Zinaida Perić, et al.. (2024). Impact of the Type of Tyrosine Kinase Inhibitor (imatinib or dasatinib) Used Before allo-HCT on Outcome of Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia. A Study on Behalf of the Acute Leukemia Working Party of the EBMT. Transplantation and Cellular Therapy. 31(1). 14.e1–14.e10.

Grob, Tim, Adil S. A. Al Hinai, Mathijs A. Sanders, et al.. (2022). Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome. Blood. 139(15). 2347–2354. 159 indexed citations breakdown →

Baron, Frédéric, Myriam Labopin, Jan J. Cornelissen, et al.. (2021). Comparison of long-term outcome for AML patients alive free of disease 2 years after allogeneic hematopoietic cell transplantation with umbilical cord blood versus unrelated donor: a study from the ALWP of the EBMT. Bone Marrow Transplantation. 56(11). 2742–2748. 3 indexed citations

Mikulska, Małgorzata, Olaf Penack, Nina Knelange, et al.. (2021). HEV infection in stem cell transplant recipients—retrospective study of EBMT Infectious Diseases Working Party. Bone Marrow Transplantation. 57(2). 167–175. 5 indexed citations

Nagler, Arnon, Myriam Labopin, Bhagirathbhai Dholaria, et al.. (2020). Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia. Clinical Cancer Research. 27(3). 843–851. 26 indexed citations

Hirschbühl, Klaus, Myriam Labopin, Mohamed Houhou, et al.. (2020). Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party. Bone Marrow Transplantation. 56(5). 1190–1199. 14 indexed citations

Poiré, Xavier, Myriam Labopin, Emmanuelle Polge, et al.. (2019). Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT. Haematologica. 105(2). 414–423. 8 indexed citations

Hayashi, Hiromi, Annalisa Ruggeri, Fernanda Volt, et al.. (2018). Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria. Bone Marrow Transplantation. 53(4). 417–421. 1 indexed citations

10.

Duinhouwer, Lucia, Nick Beije, Bronno van der Holt, et al.. (2018). Impaired thymopoiesis predicts for a high risk of severe infections after reduced intensity conditioning without anti-thymocyte globulin in double umbilical cord blood transplantation. Bone Marrow Transplantation. 53(6). 673–682. 6 indexed citations

11.

Tüysüz, Nesrin, Louis van Bloois, Stieneke van den Brink, et al.. (2017). Lipid-mediated Wnt protein stabilization enables serum-free culture of human organ stem cells. Nature Communications. 8(1). 14578–14578. 59 indexed citations

12.

Gratwohl, Aloïs, Anna Sureda, Jan J. Cornelissen, et al.. (2017). Alloreactivity: the Janus-face of hematopoietic stem cell transplantation. Leukemia. 31(8). 1752–1759. 16 indexed citations

13.

Thielen, Noortje, Jeroen J. W. M. Janssen, Mels Hoogendoorn, et al.. (2017). Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safe. European Journal Of Haematology. 100(4). 367–371. 3 indexed citations

14.

Ruggeri, Annalisa, Myriam Labopin, Boris V. Afanasyev, et al.. (2017). Post-Transplant Cyclophosphamide (PT-Cy) for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Transplantation from HLA Identical Sibling and Matched Unrelated Donor for Patients with Acute Leukemia, on Behalf of ALWP-EBMT. Blood. 130. 215–215. 6 indexed citations

15.

Walraven, Suzanna M. van, Anneke Brand, Martin B.A. Heemskerk, et al.. (2016). The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent. Haematologica. 102(1). 176–183. 18 indexed citations

16.

Shouval, Roni, Myriam Labopin, Avichai Shimoni, et al.. (2015). Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study. Journal of Clinical Oncology. 33(28). 3144–3151. 105 indexed citations

17.

Cornelissen, Jan J., Bronno van der Holt, Gregor Verhoef, et al.. (2008). Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison. Blood. 113(6). 1375–1382. 121 indexed citations

18.

Cornelissen, Jan J., Wim L.J. van Putten, Leo F. Verdonck, et al.. (2007). Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?. Blood. 109(9). 3658–3666. 345 indexed citations

19.

Görzer, Irene, Hubert G.M. Niesters, Jan J. Cornelissen, & Elisabeth Puchhammer‐Stöckl. (2006). Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes. Virus Research. 118(1-2). 105–114. 22 indexed citations

20.

Broers, Annoek E. C., Bronno van der Holt, Eric Braakman, et al.. (2005). A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell–depleted peripheral blood progenitor cell transplantation versus T cell–depleted bone marrow transplantation. Experimental Hematology. 33(8). 912–919. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact